Reproductive and hormonal factors and ovarian cancer

被引:81
作者
Chiaffarino, F
Pelucchi, C
Parazzini, F
Negri, E
Franceschi, S
Talamini, R
Conti, E
Montella, M
La Vecchia, C
机构
[1] Univ Milan, Ist Ric Farmacol Mario Negri, I-20157 Milan, Italy
[2] Univ Milan, Prima Clin Ostet Ginecol, I-20157 Milan, Italy
[3] Int Agcy Res Canc, Field & Intervent Studies Unit, F-69372 Lyon, France
[4] Ctr Riferimento Oncol, Serv Epidemiol, Aviano, PN, Italy
[5] Ist Regina Elena Studio & Cura Tumori, Rome, Italy
[6] Ist Studio & Cura Tumori Senatore Pascale, Naples, Italy
[7] Univ Milan, Ist Stat Med & Biometria, I-20122 Milan, Italy
关键词
epidemiology; female hormones; ovarian cancer; reproduction; risk factors;
D O I
10.1023/A:1011128408146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Menstrual, reproductive and hormonal factors have been related to ovarian cancer risk, but further quantification of their role in various populations is required. Patients and methods: Cases were 1031 women, below age 79, with incident, histologically confirmed epithelial ovarian cancer, and controls 2411 women, admitted between 1992 and 1999 to a network of hospitals in 4 Italian areas for acute, non-neoplastic, diseases. Odds ratios (OR) were obtained using multiple logistic regression. Results: Multiparity was associated with a significant reduction in risk of ovarian cancer (OR = 0.6 for 3, and 0.5 for greater than or equal to4 births). No consistent association was observed with time since first or last birth, nor with spontaneous or induced abortions. Late age at menarche (OR = 0.8), and early menopause (OR = 0.6) were inversely related to risk, as did long-term oral contraceptive use (OR = 0.5, for greater than or equal to5 years). Hormone replacement therapy in menopause was associated with a nonsignificantly elevated risk (OR = 1.4). The pattern of risk was similar for women with and for those without family history of breast or ovarian cancer. Conclusions: This uniquely large study confirms and further quantifies the relation between hormonal and reproductive factors and ovarian cancer. The pattern of risk observed cannot be totally explained by a role of ovulation in ovarian carcinogenesis.
引用
收藏
页码:337 / 341
页数:5
相关论文
共 27 条
[1]   PARITY, AGE AT FIRST CHILDBIRTH, AND RISK OF OVARIAN-CANCER [J].
ADAMI, HO ;
HSIEH, CC ;
LAMBE, M ;
TRICHOPOULOS, D ;
LEON, D ;
PERSSON, I ;
EKBOM, A ;
JANSON, PO .
LANCET, 1994, 344 (8932) :1250-1254
[2]  
[Anonymous], IARC MON EV CARC RIS
[3]  
Breslow NE, 1980, IARC SCI PUBLICATION, V32
[4]  
Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5
[5]  
CASAGRANDE JT, 1979, LANCET, V2, P170
[6]   Correlates of hormone replacement therapy use in Italian women, 1992-1996 [J].
Chiaffarino, F ;
Parazzini, F ;
La Vecchia, C ;
Bianchi, MM ;
Benzi, G ;
Ricci, E ;
Chiantera, V .
MATURITAS, 1999, 33 (02) :107-115
[7]   A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer [J].
Coughlin, SS ;
Giustozzi, A ;
Smith, SJ ;
Lee, NC .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (04) :367-375
[8]   POOLED ANALYSIS OF 3 EUROPEAN CASE-CONTROL STUDIES OF OVARIAN-CANCER .2. AGE AT MENARCHE AND AT MENOPAUSE [J].
FRANCESCHI, S ;
LAVECCHIA, C ;
BOOTH, M ;
TZONOU, A ;
NEGRI, E ;
PARAZZINI, F ;
TRICHOPOULOS, D ;
BERAL, V .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (01) :57-60
[9]   POOLED ANALYSIS OF 3 EUROPEAN CASE-CONTROL STUDIES OF EPITHELIAL OVARIAN-CANCER .3. ORAL-CONTRACEPTIVE USE [J].
FRANCESCHI, S ;
PARAZZINI, F ;
NEGRI, E ;
BOOTH, M ;
LAVECCHIA, C ;
BERAL, V ;
TZONOU, A ;
TRICHOPOULOS, D .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (01) :61-65
[10]   Hormone replacement therapy and the risk of epithelial ovarian carcinoma: A meta-analysis [J].
Garg, PP ;
Kerlikowske, K ;
Subak, L ;
Grady, D .
OBSTETRICS AND GYNECOLOGY, 1998, 92 (03) :472-479